EHA 2024 – Consuelo Bertossi

Consuelo Bertossi explains how TP53 mutations affect the prognosis of CLL patients and their impact on treatment decisions. She also discusses the significance of co-occurring genetic alterations and highlights the influence of TP53 mutations on the efficacy of different treatment approaches in CLL, ahead of her presentation at this year’s EHA congress.

Here is the full EHA 2024 report.